1. Zhu, Lijing, Sun, Lisha, Zhang, Ye, Zhou, Chuan-Xiang, Li, Tie-Jun. 2024. PON3::LCN1 and HTN3::MSANTD3 Gene Fusions With NR4A3/NR4A2 Expression in Salivary Acinic Cell Carcinoma. In The American journal of surgical pathology, 48, 681-690. doi:10.1097/PAS.0000000000002219. https://pubmed.ncbi.nlm.nih.gov/38682454/
2. Salas-Pérez, Francisca, Cuevas-Sierra, Amanda, Cuervo, Marta, Martínez, J Alfredo, Riezu-Boj, José Ignacio. 2021. Differentially methylated regions (DMRs) in PON3 gene between responders and non-responders to a weight loss dietary intervention: a new tool for precision management of obesity. In Epigenetics, 17, 81-92. doi:10.1080/15592294.2021.1873629. https://pubmed.ncbi.nlm.nih.gov/33427034/
3. Sanghera, Dharambir K, Manzi, Susan, Minster, Ryan L, Bontempo, Franklin, Kamboh, M Ilyas. 2007. Genetic variation in the paraoxonase-3 (PON3) gene is associated with serum PON1 activity. In Annals of human genetics, 72, 72-81. doi:. https://pubmed.ncbi.nlm.nih.gov/17900266/
4. Xiao, Jianhao, Li, Xiaodong, Yuan, Qian, Wang, Yunliang, Duan, Shiwei. . PON1 Hypermethylation and PON3 Hypomethylation are Associated with Risk of Cerebral Infarction. In Current neurovascular research, 16, 115-122. doi:10.2174/1567202616666190412154407. https://pubmed.ncbi.nlm.nih.gov/30977447/
5. Bacchetti, Tiziana, Ferretti, Gianna, Sahebkar, Amirhossein. 2017. The role of paraoxonase in cancer. In Seminars in cancer biology, 56, 72-86. doi:10.1016/j.semcancer.2017.11.013. https://pubmed.ncbi.nlm.nih.gov/29170064/